Categoría: Clinical Trials
-
The Effect of Umbilical Cord-derived Mesenchymal Stem Cell Transplantation in a Patient with Cerebral Palsy: A Case Report.
[fusion_builder_container hundred_percent=»no» hundred_percent_height=»no» hundred_percent_height_scroll=»no» hundred_percent_height_center_content=»yes» equal_height_columns=»no» menu_anchor=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» status=»published» publish_date=»» class=»» id=»» background_color=»» background_image=»» background_position=»center center» background_repeat=»no-repeat» fade=»no» background_parallax=»none» enable_mobile=»no» parallax_speed=»0.3″ video_mp4=»» video_webm=»» video_ogv=»» video_url=»» video_aspect_ratio=»16:9″ video_loop=»yes» video_mute=»yes» video_preview_image=»» border_size=»» border_color=»» border_style=»solid» margin_top=»» margin_bottom=»» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»»][fusion_builder_row][fusion_builder_column type=»1_1″ layout=»1_1″ spacing=»» center_content=»no» link=»» target=»_self» min_height=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» class=»» id=»» background_color=»» background_image=»» background_image_id=»» background_position=»left top» background_repeat=»no-repeat» hover_type=»none»…
-
Multiple Sclerosis News Today Covers Stem Cell Institute Clinical Trial for MS
[fusion_builder_container hundred_percent=»no» hundred_percent_height=»no» hundred_percent_height_scroll=»no» hundred_percent_height_center_content=»yes» equal_height_columns=»no» menu_anchor=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» class=»» id=»» background_color=»» background_image=»» background_position=»center center» background_repeat=»no-repeat» fade=»no» background_parallax=»none» enable_mobile=»no» parallax_speed=»0.3″ video_mp4=»» video_webm=»» video_ogv=»» video_url=»» video_aspect_ratio=»16:9″ video_loop=»yes» video_mute=»yes» video_preview_image=»» border_size=»» border_color=»» border_style=»solid» margin_top=»» margin_bottom=»» padding_top=»» padding_right=»» padding_bottom=»» padding_left=»»][fusion_builder_row][fusion_builder_column type=»1_1″ layout=»1_1″ spacing=»» center_content=»no» link=»» target=»_self» min_height=»» hide_on_mobile=»small-visibility,medium-visibility,large-visibility» class=»» id=»» background_color=»» background_image=»» background_position=»left top» background_repeat=»no-repeat» hover_type=»none» border_size=»0″ border_color=»» border_style=»solid»…
-
US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US
(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application…
-
New article concludes US FDA restrictions hampering stem cell therapy progress
An article published this month in Thieme Journal of Knee Surgery entitled, «The Use of Biologic Agents in Athletes with Knee Injuries» concluded that «Biologic agents… are becoming the mainstay of nonoperative therapy in the high-demand athletic population.» but «…Unfortunately, strict regulations by the FDA continue to restrict their application in clinical practice.» The good…
-
Why Stem Cells Work: Clinical Trials for Spinal Cord Injury, Multiple Sclerosis, Rheumatoid Arthritis, and Duchenne’s Muscular Dystrophy
—
por
en Bone Marrow Stem Cells, Clinical Trials, Duchenne’s muscular dystrophy, Duchenne’s muscular dystrophy, Medistem Labs Panama, Mesenchymal Stem Cells, Multiple Sclerosis, muscular dystrophy, Muscular Dystrophy, Neil Riordan PA PhD, News, Rheumatoid Arthritis, Spinal Cord Injury, Stem Cell Lecture Videos, Stem Cell Research, Stem Cell Therapy, umbilical cord tissue stem cellsNeil Riordan, PhD speaks at the Riordan-McKenna Institute and Stem Cell Institute fall seminar in Southlake, Texas on October 10, 2015. Dr. Riordan discusses: How our lab selects uses specialized screening techniques to select only the stem cells that we know will be the most useful for our patients. Only about 1 in 100 cords…